Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Parkinson Disease in United States

252 results

Sort By:

Imaging Core Aim 2, and Udall Project 2 Aim 2

Study ID: NCT06998303
Start Date: 2025-04-01
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Bipolar DBS stimulation

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Longitudinal Cognitive Assessment by BoCA

Study ID: NCT04114994
Start Date: 2019-10-01
End Date: 2029-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment

Boston Cognitive Assessment (BoCA)

Sponsor

Alzheimer's Light LLC

Source: clinicaltrials.gov

Share:
Add to list

Impact of a Biophoton Therapy on Patients With Brain Disorders

Study ID: NCT06147999
Start Date: 2023-11-08
End Date: 2026-11-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Biophotonizer - a Biophoton Generator

Sponsor

First Institute of All Medicines

Source: clinicaltrials.gov

Share:
Add to list

Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease

Study ID: NCT04799470
Start Date: 2021-05-10
End Date: 2026-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Novel DBS stimulation patterns

Sponsor

University of Nebraska

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

Study ID: NCT06753331
Start Date: 2024-12-18
End Date: 2030-12-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

DSP-1083 implantation

Sham surgery treatment

Sponsor

Sumitomo Pharma America, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Study ID: NCT06809400
Start Date: 2025-02-18
End Date: 2028-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

127

Intervention / Treatment

LY4006896

Placebo

Sponsor

Eli Lilly and Company

Source: clinicaltrials.gov

Share:
Add to list

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Study ID: NCT06170788
Start Date: 2023-12-15
End Date: 2030-05-27
Study Type

Interventional

Study Phase

Phase3

No. of Participants

614

Intervention / Treatment

Sacituzumab tirumotecan

Pembrolizumab

Supportive care measures

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease

Study ID: NCT06772220
Start Date: 2024-03-05
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Folic Acid 1 MG

Vitamin B6 25 MG

Vitamin B12

Sponsor

Oregon Health and Science University

Source: clinicaltrials.gov

Share:
Add to list

User-friendliness of a Portable Driving Simulator

Study ID: NCT03969927
Start Date: 2019-08-28
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Low-Fidelity PDS

High Fidelity Fixed-Base Simulator

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Spinal Cord Stimulation for Parkinson's Disease Rehabilitation

Study ID: NCT06804642
Start Date: 2024-12-12
End Date: 2035-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Spinal cord transcutaneous stimulation (scTS)

Sponsor

University of Louisville

Source: clinicaltrials.gov

Share:
Add to list